XML 69 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Collaboration Agreements and Revenues - Summary of Revenue Recognized Under the Collaboration Agreements - Additional Information 4 (Detail)
3 Months Ended
Sep. 30, 2020
USD ($)
Japan [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing $ 0
Japan [Member] | Astellas Agreement [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations 100,000
Europe [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing 31,500,000
Europe [Member] | Astellas Agreement [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations 1,300,000
U.S./RoW and China [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Remainder of transaction price, variable consideration from estimated future co-development billing 52,300,000
U.S./RoW and China [Member] | Astellas Agreement [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations (600,000)
China [Member] | AstraZeneca Agreements [Member]  
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]  
Changes in revenue due to prior period adjustment of performance obligations $ (2,000,000.0)